Navigation path

EDCTP


Tuberculosis

European and Developing Countries Clinical Trials Programme
Framework programme:
5
Project number:
QLK2-CT-2002-30198
EC contribution:
€ 1 240 000
Duration:
12 months
Type:
AM
Starting date:
1 August 2002

Keywords: Life sciences; medicine; health; safety; scientific research; social aspects

Summary:

The objective of this Accompanying Measure is to create the European Clinical Trials Platform for Poverty Related Diseases (ECTP). This will be achieved by a systematic analysis of the proposed functions and operational structure of the ECTP, based on Article 169 of the Treaty of Rome. This analysis will be also based on information regarding EU National Programmes, other European and DC initiatives, and extensive consultations with the stakeholders. The ultimate goal of the future ECTP will be that new vaccines, drugs and health interventions could be properly and efficiently tested for safety, efficacy and effectiveness, and finally delivered faster in an improved health system to the needy populations. The ECTP must be driven by the needs of DCs. Its main operational goal will be to accelerate the development and evaluation of effective interventions against diseases linked to poverty.
The objective of this accompanying measure is to create the European Clinical Trials Platform (ECTP) for poverty related diseases (PRD), which will provide a new service for the EU research community, and add value and coherence to national R&D activities. The ultimate goal is that new vaccines, drugs and health interventions can be properly and efficiently tested for safety, efficacy and effectiveness, and delivered faster in an improved health system to the needy populations. The ECTP will be driven by the needs of developing countries. Its main operational goal will be to accelerate the development and evaluation of effective interventions against PRDs.
The four main agreed functions of the ECTP will be:
1) strengthening the capacity to conduct clinical trials under good clinical practice (GCP) in developing countries
2) networking relevant activities in EU Member States
3) initiating and arranging the design and conduct of PRD clinical trials
4) supporting the external and public relations of its activities

[+] Read More